• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹腔内热灌注化疗临床输送系统。

Clinical delivery system for intraperitoneal hyperthermic chemotherapy.

作者信息

Spratt J S, Adcock R A, Muskovin M, Sherrill W, McKeown J

出版信息

Cancer Res. 1980 Feb;40(2):256-60.

PMID:6766084
Abstract

A 35-year-old man was treated for pseudomyxoma peritonei by surgery and by thermal infusion and chemotherapy with a machine designed specifically for the treatment of cancers of serosal surfaces. After extensive abdominal resection and closure, the patient's peritoneal cavity was instilled with 2.5 liters of 5% lactated Ringer's solution. He was then attached to hyperthermic perfusion system which elevated the i.p. temperature by warming (to 42 degrees) and recirculating the effusion solution. When the 42 degrees i.p. temperature was attained (after 1.5 hr), chemotherapy was added to the recirculating effusion. A second procedure followed 8 days later. The patient's postoperative course was uneventful except for minor pulmonary atelectasis with bacteremia. Hyperthermic perfusion was tolerated well and was evaluated as safe for intracavitary cancer treatment.

摘要

一名35岁男性因腹膜假黏液瘤接受了手术治疗,并使用专门设计用于治疗浆膜表面癌症的机器进行热灌注和化疗。在进行广泛的腹部切除和缝合后,向患者的腹腔内注入了2.5升5%的乳酸林格氏液。然后将他连接到热灌注系统,该系统通过加热(至42摄氏度)和循环渗出液来提高腹腔内温度。当腹腔内温度达到42摄氏度时(1.5小时后),将化疗药物加入循环的渗出液中。8天后进行了第二次手术。除了伴有菌血症的轻微肺不张外,患者的术后过程顺利。热灌注耐受性良好,被评估为对腔内癌症治疗安全。

相似文献

1
Clinical delivery system for intraperitoneal hyperthermic chemotherapy.腹腔内热灌注化疗临床输送系统。
Cancer Res. 1980 Feb;40(2):256-60.
2
Experimental development of an intra-abdominal chemohyperthermia model using a closed abdomen technique and a PRS-1.0 Combat CO2 recirculation system.采用封闭腹部技术和 PRS-1.0 Combat CO2 再循环系统,对腹腔内化学热疗模型进行实验开发。
Surgery. 2014 Apr;155(4):719-25. doi: 10.1016/j.surg.2013.12.005. Epub 2013 Dec 14.
3
Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis.腹膜癌的减瘤手术及腹腔热灌注化疗
Isr Med Assoc J. 2007 Nov;9(11):787-90.
4
[Treatment of peritoneal carcinomatosis with surgery and hyperthermic peroperative intraperitoneal chemotherapy (HIPEC): new aspects and validated indications].[手术联合术中腹腔热灌注化疗(HIPEC)治疗腹膜癌:新进展与有效适应证]
Bull Cancer. 2008 Jan;95(1):141-5. doi: 10.1684/bdc.2008.0553.
5
Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin.细胞减灭术联合腹腔内热化疗治疗胃肠道来源的播散性腹膜癌。
Am Surg. 2000 Jun;66(6):561-8.
6
[Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].[细胞减灭术联合腹腔热灌注化疗(IHPC)治疗腹膜癌病:术后发病率、死亡率及短期随访]
Ann Ital Chir. 2008 Jul-Aug;79(4):231-9.
7
Feasibility of radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendiceal origin.根治性细胞减灭术和腹腔内热灌注化疗治疗阑尾来源的假性黏液瘤腹膜假性黏液瘤的可行性。
Scand J Surg. 2013;102(3):145-51. doi: 10.1177/1457496913490463.
8
Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.细胞减灭术联合腹腔热灌注化疗治疗腹膜假黏液瘤患者中循环肿瘤标志物的预后价值
Ann Surg Oncol. 2007 Aug;14(8):2300-8. doi: 10.1245/s10434-007-9393-9. Epub 2007 May 18.
9
Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies.腹腔镜与开放减瘤手术加腹腔热灌注化疗治疗腹膜表面恶性肿瘤的术后结局
Eur J Surg Oncol. 2014 Aug;40(8):957-62. doi: 10.1016/j.ejso.2013.10.002. Epub 2013 Oct 16.
10
Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy.热灌注腹腔化疗中的药物、载体溶液及温度
J Surg Oncol. 2008 Sep 15;98(4):247-52. doi: 10.1002/jso.21051.

引用本文的文献

1
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Recurrent Endometrial Cancer With Peritoneal Carcinomatosis.细胞减灭术与腹腔热灌注化疗治疗复发性子宫内膜癌伴腹膜转移瘤
In Vivo. 2025 Sep-Oct;39(5):2832-2841. doi: 10.21873/invivo.14083.
2
Management and Outcomes of Urinary Tract Involvement in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC): A Retrospective Cohort Study.减瘤性手术联合热灌注腹腔化疗(CRS/HIPEC)中泌尿系统受累的管理及结局:一项回顾性队列研究
Medicina (Kaunas). 2025 Jul 23;61(8):1331. doi: 10.3390/medicina61081331.
3
Asian consensus on normothermic intraperitoneal and systemic treatment for gastric cancer with peritoneal metastasis.
亚洲关于胃癌腹膜转移常温腹腔及全身治疗的共识
Gastric Cancer. 2025 Jul 14. doi: 10.1007/s10120-025-01631-9.
4
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy outcomes in peritoneal carcinomatosis: 11-year tertiary-center experience.细胞减灭术与热灌注化疗治疗腹膜癌的效果:三级中心11年经验
BMC Cancer. 2025 Mar 15;25(1):479. doi: 10.1186/s12885-025-13858-x.
5
Evolution in the Surgical Management of Gastric Cancer Peritoneal Metastases.胃癌腹膜转移外科治疗的进展
Cancers (Basel). 2024 Dec 31;17(1):100. doi: 10.3390/cancers17010100.
6
Challenges following CRS and HIPEC surgery in cancer patients with peritoneal metastasis: a comprehensive review of clinical outcomes.伴有腹膜转移的癌症患者接受细胞减灭术和热灌注化疗手术后面临的挑战:临床结局的全面综述
Front Surg. 2024 Dec 2;11:1498529. doi: 10.3389/fsurg.2024.1498529. eCollection 2024.
7
Efficacy and safety of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with pancreatic cancer peritoneal metastasis.细胞减灭术联合腹腔热灌注化疗治疗胰腺癌腹膜转移患者的疗效和安全性。
World J Surg Oncol. 2024 Sep 2;22(1):212. doi: 10.1186/s12957-024-03464-9.
8
Progress on immuno-microenvironment and immune-related therapies in patients with pseudomyxoma peritonei.腹膜假性黏液瘤患者免疫微环境及免疫相关治疗的研究进展。
Cancer Biol Med. 2024 Jul 18;21(7):586-605. doi: 10.20892/j.issn.2095-3941.2024.0109.
9
Clinical significance of circulating tumor cells in colorectal cancer with peritoneal metastases: a prospective cohort study using a novel method for monitoring treatment response, and assessing minimal residual disease.循环肿瘤细胞在伴有腹膜转移的结直肠癌中的临床意义:一项前瞻性队列研究,采用一种监测治疗反应和评估微小残留病的新方法
Int J Surg. 2024 Nov 1;110(11):7187-7195. doi: 10.1097/JS9.0000000000001906.
10
Long-term outcomes and survival analysis of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei at a newly established peritoneal malignancy centre in Japan.在日本一家新成立的腹膜恶性肿瘤中心,对腹膜假黏液瘤患者进行细胞减灭术联合腹腔内热化疗的长期预后及生存分析。
Ann Gastroenterol Surg. 2024 Mar 11;8(4):701-710. doi: 10.1002/ags3.12791. eCollection 2024 Jul.